Abstract
The master regulator of neuroendocrine differentiation, achaete-scute complex homolog 1 (ASCL1) defines a subgroup of lung adenocarcinoma. However, the mechanistic role of ASCL1 in lung tumorigenesis and its relation to the immune microenvironment is principally unknown. Here, the immune landscape of ASCL1-positive lung adenocarcinomas was characterized by immunohistochemistry. Furthermore, ASCL1 was transduced in mouse lung adenocarcinoma cell lines and comparative RNA-sequencing and secretome analyses were performed. The effects of ASCL1 on tumorigenesis were explored in an orthotopic syngeneic transplantation model. ASCL1-positive lung adenocarcinomas revealed lower infiltration of CD8+, CD4+, CD20+, and FOXP3+ lymphocytes and CD163+ macrophages indicating an immune desert phenotype. Ectopic ASCL1 upregulated cyclin transcript levels, stimulated cell proliferation, and enhanced tumor growth in mice. ASCL1 suppressed secretion of chemokines, including CCL20, CXCL2, CXCL10, and CXCL16, indicating effects on immune cell trafficking. In accordance with lower lymphocytes infiltration, ASCL1-positive lung adenocarcinomas demonstrated lower abundance of CXCR3-and CCR6-expressing cells. In conclusion, ASCL1 mediates its tumor-promot...Continue Reading
References
Dec 3, 2005·Cancer Research·Hirotaka OsadaTakashi Takahashi
Mar 15, 2008·Cancer Research·Hirotaka OsadaTakashi Takahashi
Mar 19, 2009·Cancer Research·Roy-Akira SaitoKohei Miyazono
Nov 3, 2009·Immunity·Natalia Martin-OrozcoChen Dong
Jan 22, 2011·Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer·William D TravisDavid Yankelewitz
Sep 29, 2011·PloS One·Sophie KirshbergOri Wald
Jul 31, 2013·Immunity·Daniel S Chen, Ira Mellman
May 16, 2015·Cancer Letters·Dawei YangChunxue Bai
Sep 5, 2015·International Journal of Cancer. Journal International Du Cancer·Lydia MederReinhard Buettner
Oct 20, 2015·Cancer Letters·Haidong TangYang-Xin Fu
Oct 28, 2015·Nature·Dongjun PengWeiping Zou
Oct 28, 2015·PloS One·Hirotaka MatsuzakiYasuhiro Yamauchi
Feb 5, 2016·Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer·Roy M BremnesTom Dønnem
Jul 2, 2016·Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer·Ting-Yuan David ChengMary E Reid
Jul 28, 2016·Cell Reports·Mark D BorromeoJane E Johnson
Aug 9, 2016·BMC Cancer·Johanna S M MattssonMaria A Svensson
Oct 5, 2016·JCI Insight·Dijana DjureinovicPatrick Micke
Oct 5, 2016·JCI Insight·Patrick H LizotteKwok-Kin Wong
Jan 20, 2017·Nature·Daniel S Chen, Ira Mellman
Apr 28, 2017·Journal of Thoracic Disease·Artjoms Spaks
May 31, 2017·Nature Reviews. Immunology·Nisha NagarshethWeiping Zou
Jul 10, 2017·Cancer Letters·Xiangjiao MengJinming Yu
Oct 4, 2017·American Journal of Physiology. Lung Cellular and Molecular Physiology·Masafumi HorieTakahide Nagase
Dec 29, 2017·The Journal of Pathology·Artur MezheyeuskiPatrick Micke
Apr 19, 2018·International Journal of Cancer. Journal International Du Cancer·Linnéa La FleurJohan Botling
Jun 7, 2018·Journal for Immunotherapy of Cancer·Tolga TuranJosue Samayoa
Aug 20, 2018·Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer·Naoya MiyashitaTakahide Nagase
Oct 10, 2018·Cancer Discovery·Shunsuke KitajimaDavid A Barbie
Feb 20, 2019·Cancer Discovery·Triparna SenLauren A Byers
Mar 31, 2019·Nature Reviews. Cancer·Charles M RudinAdi F Gazdar
Jun 30, 2019·Journal of Hematology & Oncology·Yaru TianJinming Yu
Oct 24, 2019·Cancer Letters·Chengming LiuJie He
Feb 19, 2020·Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer·Carminia M Della CorteLauren A Byers
Mar 24, 2020·Cancer Letters·Chaoqi ZhangJie He